Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2019
Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysisYen-Chun Liu, Elizabeth Margolskee, John N Allan, et al.
American Journal of Hematology|February 14, 2023
Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemiaMateo Mejia Saldarriaga, Mohammad Alhomoud, Gail Roboz, et al.
Cancer Research|May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy ResponsesTiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Blood Advances|April 10, 2024
An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLLAdam S Kittai, John N Allan, Dan James, et al.
Blood|March 31, 2021
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX modelsAndrea Iannello, Nicoletta Vitale, Silvia Coma, et al.
Haematologica|September 2, 2017
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitorTiziana Vaisitti, Federica Gaudino, Samedy Ouk, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 30, 2023
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with DasatinibIvo N SahBandar, Chandler B Sy, Tayler van den Akker, et al.
Leukemia|August 31, 2019
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Leukemia|December 15, 2019
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2023
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus VenetoclaxNitin Jain, Lisa J Croner, John N Allan, et al.
Pageof 6